OncoCyte Corp (OCX) has 63 open-market insider trades by 24 insiders since 2018. The most active filer is Broadwood Partners, L.P., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Broadwood Partners, L.P. | 10% Owner | — | 6 | $65.6M | 2025-02-06 |
| Ronald Asbury Andrews | CEO | — | 6 | $43.1M | 2022-12-01 |
| Broadwood Capital Inc. via Neal C. Bradsher | 10% Owner | — | 4 | $24.5M | 2024-10-02 |
| Neal C. Bradsher | 10% Owner | — | 4 | $22.4M | 2021-01-20 |
| Lineage Cell Therapeutics, Inc. | — | — | 2 | $16.9M | 2020-01-02 |
| PURA VIDA Investments, LLC via Efrem Kamen | 10% Owner | — | 3 | $15.8M | 2023-04-05 |
| Biotime Inc. | 10% Owner | — | 1 | $4.5M | 2019-07-05 |
| Patrick W. Smith | 10% Owner | — | 5 | $2.6M | 2025-02-07 |
| Andrew Arno | Dir | — | 6 | $685K | 2024-12-26 |
| Andrea S. James | CFO | — | 3 | $646K | 2025-02-07 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Andrea S. James | CFO | Buy | $400K | 2025-02-07 |
| Patrick W. Smith | 10% Owner | Buy | $2.2M | 2025-02-07 |
| Broadwood Partners, L.P. | 10% Owner | Buy | $21.2M | 2025-02-06 |
| Patrick W. Smith | 10% | Buy | $2K | 2025-01-31 |
| Patrick W. Smith | 10% | Buy | $8K | 2025-01-29 |
| Patrick W. Smith | 10% | Buy | $34K | 2025-01-13 |
Companies that share insiders with OCX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Patrick W. Smith | 10% Owner | Buy | $384K | 2024-12-26 |
| Andrew Arno | Director | Buy | $26K | 2024-12-26 |
| Andrea S. James | CFO | Buy | $46K | 2024-12-05 |
| Broadwood Capital Inc. | 10% Owner | Buy | $7.8M | 2024-10-02 |
| Andrea S. James | CFO | Buy | $200K | 2024-10-02 |
| Andrew Arno | Director | Buy | $200K | 2024-04-11 |
| Broadwood Partners, L.P. | 10% Owner | Buy | $7.1M | 2024-04-11 |
| Josh Riggs | President | Buy | $10K | 2024-04-11 |
| Alfred D. Kingsley | Director | Buy | $6K | 2023-06-14 |